Clinical Trial Update: Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking [Phase 3]

View source ↗

Summary

Phase 3 trial update on varenicline for smoking cessation in smokers with cardiovascular disease, reporting efficacy and safety results. Results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Nicotine Dependence

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2009-04-29